Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220031) titled 'Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay' on Oct. 21.
Study Type: Observational
Primary Sponsor: State University of New York - Upstate Medical University
Condition:
Osmolality Disturbance
Lab Interference
Intervention:
Drug: Activated Charcoal
Recruitment Status: Not recruiting
Date of First Enrollment: November 15, 2025
Target Sample Size: 8
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07220031
Published by HT Digital Content Services with permission from Health Daily Digest....